Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 2, 2022New England Journal of MedicineOpen Access

Covid-19 Vaccine Protection among Children and Adolescents in Qatar

View Full Paper
Ask AI
Bookmark
Share

Authors

HCHiam ChemaitellyWeill Cornell Medical College in QatarSASawsan AlMukdadQatar UniversityHAHoussein H. AyoubQatar University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chemaitelly et al. (2022) studied this question.

synapsesocial.com/papers/6a71f400439bab0cabc3b82dhttps://doi.org/10.1056/nejmoa2210058
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar2022 · 239 citations
  2. 2Vaccine effectiveness with BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine against reported SARS-CoV-2 Delta and Omicron infection among adolescents, Norway, August 2021 to January 20222022 · 20 citations
  3. 3Risk of adverse events after covid-19 in Danish children and adolescents and effectiveness of BNT162b2 in adolescents: cohort study2022 · 54 citations
  4. 4Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available: Table 1.2016 · 3,087 citations